Atenda Health Care Solutions is a Hollywood, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Accutron Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
For more than 25 years, Code Blue Corporation has been the industry leading manufacturer of durable emergency communication solutions. The pioneer in developing and producing vandal-resistant Blue Light Emergency Phones at thousands of education, corporate, hospital, airport and municipal locations around the world, Code Blue’s expansion includes the innovation of advanced public address and mass notification systems to provide a complete end-to-end solution. Founded to address the growing need for sophisticated audio security solutions, Code Blue offers American-made Help Point®, Emergency Signaling, Incident Response and Systems Management products that are innovative, rugged, powerful and easily integrated. Code Blue’s evolution continues with the engineering of new software and hardware designed to meet the ever-changing needs of customers who require an advanced level of incident deterrence that establishes a safe environment. No matter where you go, you can feel safe knowing that there is help at the touch of a button.
Our goal at Allen Medical Systems is to provide the highest product innovation and technology to our customers. Our most recent step in achieving that objective has been to include the products of OR Direct, Hill-Rom Surgical Surfaces, and Ronci
BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.